Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Hallvard Holdaas
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Chemicals & Drugs
Concepts & Ideas
Disorders
Anatomy
Physiology
Sign-in to see full Profile
Network (preview)
32
Fauchald, Per
29
Hartmann, Anders
21
Fellström, Bengt
12
Berg, Knut Joachim
12
Midtvedt, Karsten
11
Neumayer, Hans-Hellmut
11
Jardine, Alan
10
Sødal, G
10
Leivestad, Torbjørn
10
Madsen, Søren
10
Maes, Bart
10
Brekke, Inge
10
Grönhagen-Riska, Carola
9
Cole, Edward
8
Asberg, Anders
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Hallvard Holdaas (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2010: Abedini Sadollah; Meinitzer Andreas; Holme Ingar; März Winfried; Weihrauch Gisela; Fellstrøm Bengt; Jardine Alan; Holdaas Hallvard
Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients.
Kidney international 2010;77(1):44-50.
-
2010: Holme Ingar; Fellstrom Bengt; Jardine Alan; Holdaas Hallvard
Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients.
Atherosclerosis 2010;208(1):234-9.
-
2009: Mjøen Geir; Øyen Ole; Holdaas Hallvard; Midtvedt Karsten; Line Pål-Dag
Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry.
Transplantation 2009;88(11):1273-9.
-
2009: Witczak Bartlomiej J; Leivestad Torbjørn; Line Pål Dag; Holdaas Hallvard; Reisaeter Anna V; Jenssen Trond G; Midtvedt Karsten; Bitter Jan; Hartmann Anders
Experience from an active preemptive kidney transplantation program--809 cases revisited.
Transplantation 2009;88(5):672-7.
-
2009: Valderhaug Tone G; Jenssen Trond; Hartmann Anders; Midtvedt Karsten; Holdaas Hallvard; Reisaeter Anna V; Hjelmesaeth Jøran
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
Transplantation 2009;88(3):429-34.
-
2009: Abedini Sadollah; Holme Ingar; März Winfried; Weihrauch Gisela; Fellström Bengt; Jardine Alan; Cole Edward; Maes Bart; Neumayer Hans-Hellmut; Grønhagen-Riska Carola; Ambühl Patrice; Holdaas Hallvard;
Inflammation in renal transplantation.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(7):1246-54.
-
2009: Midtvedt Karsten; Bitter Jan; Dørje Christina; Bjørneklett Rune; Holdaas Hallvard
Belatacept as immunosuppression in patient with recurrence of hemolytic uremic syndrome after renal transplantation.
Transplantation 2009;87(12):1901-3.
-
2009: Fellström Bengt C; Jardine Alan G; Schmieder Roland E; Holdaas Hallvard; Bannister Kym; Beutler Jaap; Chae Dong-Wan; Chevaile Alejandro; Cobbe Stuart M; Grönhagen-Riska Carola; De Lima José J; Lins Robert; Mayer Gert; McMahon Alan W; Parving Hans-Henrik; Remuzzi Giuseppe; Samuelsson Ola; Sonkodi Sandor; Sci D; Süleymanlar Gultekin; Tsakiris Dimitrios; Tesar Vladimir; Todorov Vasil; Wiecek Andrzej; Wüthrich Rudolf P; Gottlow Mattis; Johnsson Eva; Zannad Faiez;
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
The New England journal of medicine 2009;360(14):1395-407.
-
2009: Norby Gudrun E; Holme Ingar; Fellström Bengt; Jardine Alan; Cole Edward; Abedini Sadollah; Holdaas Hallvard;
Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
Arthritis and rheumatism 2009;60(4):1060-4.
-
2009: Fellström Bengt; Holdaas Hallvard; Jardine Alan G; Svensson Maria K; Gottlow Mattis; Schmieder Roland E; Zannad Faiez;
Cardiovascular disease in patients with renal disease: the role of statins.
Current medical research and opinion 2009;25(1):271-85.
-
2009: Abedini Sadollah; Holme Ingar; Fellström Bengt; Jardine Alan; Cole Edward; Maes Bart; Holdaas Hallvard;
Cerebrovascular events in renal transplant recipients.
Transplantation 2009;87(1):112-7.
-
2009: Falck Pål; Midtvedt Karsten; Vân Lê Thanh Trúc; Storehagen Live; Holdaas Hallvard; Hartmann Anders; Asberg Anders
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients.
Clinical pharmacokinetics 2009;48(9):615-23.
-
2009: Bremer Sara; Vethe Nils T; Rootwelt Helge; Jørgensen Pål F; Stenstrøm Jean; Holdaas Hallvard; Midtvedt Karsten; Bergan Stein
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.
Journal of translational medicine 2009;7():64.
-
2008: Gunther Anne; Foss Aksel; Holdaas Hallvard; Brabrand Knut; Hartmann Anders; Line Paal-Dag; Midtvedt Karsten
Increased peak systolic velocity in the renal artery of paediatric kidneys transplanted to adult recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(12):4041-3.
-
2008: Holdaas H; Bentdal O; Pfeffer P; Mjørnstedt L; Solbu D; Midtvedt K
Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study.
Clinical transplantation 2008;22(3):366-71.
-
2008: Esnault Vincent L M; Brown Edwina A; Apetrei Eduard; Bagon Jacques; Calvo Carlos; DeChatel Rudolf; Holdaas Hallvard; Krcmery Silvester; Kobalava Zhanna;
The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Clinical therapeutics 2008;30(3):482-98.
-
2008: Falck Pål; Vethe Nils Tore; Asberg Anders; Midtvedt Karsten; Bergan Stein; Reubsaet Jan Leo Egge; Holdaas Hallvard
Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(3):1048-53.
-
2008: Holdaas Hallvard
Statin therapy for prevention of coronary artery disease. The earlier the better or the longer the better?
European heart journal 2008;29(4):425-6.
-
2008: Foss Aksel; Gunther Anne; Line Pål-Dag; Brabrand Knut; Holdaas Hallvard; Hartmann Anders; Midtvedt Karsten
Long-term clinical outcome of paediatric kidneys transplanted to adults.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(2):726-9.
-
2007: Ekberg Henrik; Kyllönen Lauri; Madsen Søren; Grave Gisle; Solbu Dag; Holdaas Hallvard
Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: a multinational survey of nephrologists.
Transplantation 2007;84(8):1052-4.
-
2007: Singer Jonathan B; Holdaas Hallvard; Jardine Alan G; Fellstrøm Bengt; Os Ingrid; Bermann Georgina; Meyer Joanne M;
Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients.
Journal of lipid research 2007;48(9):2072-8.
-
2007: Holdaas Hallvard; Wanner Christoph; Abletshauser Claudia; Gimpelewicz Claudio; Isaacsohn Jonathan
The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
International journal of cardiology 2007;117(1):64-74.
-
2007: Ekberg Henrik; Kyllönen Lauri; Madsen Søren; Grave Gisle; Solbu Dag; Holdaas Hallvard
Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients.
Transplantation 2007;83(3):282-9.
-
2007: Fellström Bengt; Holdaas Hallvard; Jardine Alan G; Rose Helen; Schmieder Roland; Wilpshaar Wim; Zannad Faiez;
Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study.
Kidney & blood pressure research 2007;30(5):314-22.
-
2006: Fellström Bengt; Abedini Sadollah; Holdaas Hallvard; Jardine Alan G; Staffler Beatrix; Gimpelewicz Claudio;
No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
Clinical transplantation 2006;20(6):732-9.
-
2006: Holdaas Hallvard; Westlie Lars
[A renaissance for home hemodialysis?]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2006;126(21):2785.
-
2006: Soveri Inga; Holdaas Hallvard; Jardine Alan; Gimpelewicz Claudio; Staffler Beatrix; Fellström Bengt
Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(8):2282-9.
-
2006: Asberg Anders; Midtvedt Karsten; Line Pål D; Narverud Janicke; Holdaas Hallvard; Jenssen Trond; Reisaeter Anna V; Johnsen Linda F; Fauchald Per; Hartmann Anders
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
Transplantation 2006;82(1):62-8.
-
2006: Oien Cecilia Montgomery; Reisaeter Anna Varberg; Os Ingrid; Jardine Alan; Fellström Bengt; Holdaas Hallvard
Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study.
Clinical transplantation 2006;20(3):374-82.
-
2006: Hartmann Anders; Holdaas Hallvard; Os Ingrid; Hunderi Odd Helge; Hallan Stein; Widerøe Tor Erik; Svarstad Einar; Selvig Kristian; Skjønsberg Helge; Toft Ingrid
[Staging and measurement of renal function in chronic renal conditions]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2006;126(9):1198-200.
-
2006: Holdaas H; Hagen E; Asberg A; Lund K; Hartman A; Vaidyanathan S; Prasad P; He Y L; Yeh C M; Bigler H; Rouilly M; Denouel J
Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipients.
International journal of clinical pharmacology and therapeutics 2006;44(4):163-71.
-
2006: Holdaas Hallvard; Singh Debbie
Fluvastatin may be similarly effective in older and younger people.
Evidence-based cardiovascular medicine 2006;10(1):11-2.
-
2006: Hjelmesaeth J; Hartmann A; Leivestad T; Holdaas H; Sagedal S; Olstad M; Jenssen T
The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events.
Kidney international 2006;69(3):588-95.
-
2006: Holdaas Hallvard; Wanner Christoph; Abletshauser Claudia; Gimpelewicz Claudio; Isaacsohn Jonathan
The renal safety profile of fluvastatin: results of a pooled analysis.
Renal failure 2006;28(6):487-92.
-
2005: Holdaas H; Fellström B; Cole E; Nyberg G; Olsson A G; Pedersen T R; Madsen S; Grönhagen-Riska C; Neumayer H-H; Maes B; Ambühl P; Hartmann A; Staffler B; Jardine A G;
Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(12):2929-36.
-
2005: Jardine Alan G; Fellström Bengt; Logan John O; Cole Edward; Nyberg Gudrun; Grönhagen-Riska Carola; Madsen Søren; Neumayer Hans-Hellmut; Maes Bart; Ambühl Patrice; Olsson Anders G; Pedersen Terje; Holdaas Hallvard
Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(3):529-36.
-
2005: Lemahieu W P D; Hermann M; Asberg A; Verbeke K; Holdaas H; Vanrenterghem Y; Maes B D
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(9):2236-43.
-
2005: Fellström B; Jardine A G; Soveri I; Cole E; Neumayer H-H; Maes B; Gimpelewicz C; Holdaas H;
Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(8):1986-91.
-
2005: Holdaas Hallvard; Fellström Bengt; Jardine Alan G;
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: lessons to be learnt from the assessment of Lescol in renal transplantation (ALERT) trial.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(6):1574-5.
-
2005: Fellström Bengt; Zannad Faiez; Schmieder Roland; Holdaas Hallvard; Jardine Alan; Rose Helen; Wilpshaar Wim;
Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study.
Current controlled trials in cardiovascular medicine 2005;6(1):9.
-
2005: Fellström Bengt; Jardine Alan G; Soveri Inga; Cole Edward; Grönhagen-Riska Carola; Neumayer Hans H; Maes Bart; Gimpelewicz Claudio; Holdaas Hallvard;
Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial.
Transplantation 2005;79(9):1160-3.
-
2005: Holdaas Hallvard; Fellström Bengt; Jardine Alan G; Nyberg Gudrun; Grönhagen-Riska Carola; Madsen Sören; Neumayer Hans-Hellmut; Cole Edward; Maes Bart; Ambühl Patrice; Logan John O; Staffler Beatrix; Gimpelewicz Claudio;
Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(5):974-80.
-
2005: Hermann Monica; Asberg Anders; Christensen Hege; Reubsaet Jan Leo Egge; Holdaas Hallvard; Hartmann Anders
Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients.
European journal of clinical pharmacology 2005;61(1):59-62.
-
2005: Fellström Bengt; Holdaas Hallvard; Jardine Alan G; Nyberg Gudrun; Grönhagen-Riska Carola; Madsen Søren; Neumayer Hans-Hellmut; Cole Edward; Maes Bart; Ambühl Patrice; Olsson Anders G; Staffler Beatrix; Pedersen Terje R;
Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.
Transplantation 2005;79(2):205-12.
-
2005: Holdaas Hallvard
Preventing cardiovascular outcome in patients with renal impairment: is there a role for lipid-lowering therapy?
American journal of cardiovascular drugs : drugs, devices, and other interventions 2005;5(4):255-69.
-
2005: Corsini Alberto; Holdaas Hallvard
Fluvastatin in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
Renal failure 2005;27(3):259-73.
-
2004: Hermann M; Asberg A; Christensen H; Holdaas H; Hartmann A; Reubsaet J L E
Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients.
Clinical pharmacology and therapeutics 2004;76(4):388-91.
-
2004: Fellström Bengt; Holdaas Hallvard; Jardine Alan G; Holme Ingar; Nyberg Gudrun; Fauchald Per; Grönhagen-Riska Carola; Madsen Søren; Neumayer Hans-Hellmut; Cole Edward; Maes Bart; Ambühl Patrice; Olsson Anders G; Hartmann Anders; Logan John O; Pedersen Terje R;
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.
Kidney international 2004;66(4):1549-55.
-
2004: Asberg Anders; Holdaas Hallvard
Fluvastatin and fluvastatin extended release: a clinical and safety profile.
Expert review of cardiovascular therapy 2004;2(5):641-52.
-
2004: Jardine Alan G; Holdaas Hallvard; Fellström Bengt; Cole Edward; Nyberg Gudrun; Grönhagen-Riska Carola; Madsen Søren; Neumayer Hans-Hellmut; Maes Bart; Ambühl Patrice; Olsson Anders G; Holme Ingar; Fauchald Per; Gimpelwicz Claudio; Pedersen Terje R;
fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(6):988-95.
-
2003: Asberg Anders; Holdaas Hallvard; Jardine Alan G; Edvardsen Cecilie; Hartmann Anders
Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation.
Clinical transplantation 2003;17(4):385-90.
-
2003: Holdaas H; Jardine A
Acute renal allograft rejections, a role for statins?
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2003;55(2):111-9.
-
2003: Holdaas Hallvard; Fellström Bengt; Jardine Alan G; Holme Ingar; Nyberg Gudrun; Fauchald Per; Grönhagen-Riska Carola; Madsen Søren; Neumayer Hans-Hellmut; Cole Edward; Maes Bart; Ambühl Patrice; Olsson Anders G; Hartmann Anders; Solbu Dag O; Pedersen Terje R;
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.
Lancet 2003;361(9374):2024-31.
-
2003: Jakobsen A; Holdaas H; Leivestad T
Ethics and safety of living kidney donation.
Transplantation proceedings 2003;35(3):1177-8.
-
2003: Fellström Bengt C; Holdaas Hallvard; Jardine Alan G
Why do we need a statin trial in hemodialysis patients?
Kidney international. Supplement 2003;(84):S204-6.
-
2003: Hartmann Anders; Fauchald Per; Westlie Lars; Brekke Inge B; Holdaas Hallvard
The risk of living kidney donation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(5):871-3.
-
2003: Westlie Lars; Leivestad Torbjørn; Holdaas Hallvard; Lien Bjørn; Hartmann Anders; Fauchald Per
[Is current practice concerning living donors in kidney transplantations acceptable?]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2003;123(8):1063-5.
-
2003: Westlie Lars; Leivestad Torbjørn; Holdaas Hallvard; Lien Bjørn; Meyer Käthe; Fauchald Per
[How are living kidney donors doing?]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2003;123(8):1060-2.
-
2003: Westlie L; Leivestad T; Holdaas H; Lien B; Meyer K; Fauchald P
Report from the Norwegian National Hospitals Living Donor Registry: one-year data, January 1, 2002.
Transplantation proceedings 2003;35(2):777-8.
-
2003: Ballantyne Christie M; Corsini Alberto; Davidson Michael H; Holdaas Hallvard; Jacobson Terry A; Leitersdorf Eran; März Winfried; Reckless John P D; Stein Evan A
Risk for myopathy with statin therapy in high-risk patients.
Archives of internal medicine 2003;163(5):553-64.
-
2002: Holdaas Hallvard; Julian Desmond
The use of statins after solid organ transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(8):1537.
-
2002: Os Ingrid; Stenehjem Aud; Høieggen Aud; Draganov Branimir; Jenssen Trond; Holdaas Hallvard
[Type 2 diabetes and nephropathy--new studies, new treatment strategies?]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2002;122(9):918-20.
-
2001: Midtvedt K; Hartmann A; Foss A; Fauchald P; Nordal K P; Rootwelt K; Holdaas H
Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril.
Transplantation 2001;72(11):1787-92.
-
2001: Midtvedt K; Hartmann A; Holdaas H; Fauchald P
Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial.
Clinical transplantation 2001;15(6):426-31.
-
2001: Asberg A; Hartmann A; Fjeldså E; Bergan S; Holdaas H
Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2001;1(4):382-6.
-
2001: Holdaas H; Jardine A G; Wheeler D C; Brekke I B; Conlon P J; Fellstrøm B; Hammad A; Holme I; Isoniemi H; Moore R; Rowe P A; Sweny P; Talbot D A; Wadstrøm J; Østraat Ø
Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial.
Kidney international 2001;60(5):1990-7.
-
2001: Asberg A; Hartmann A; Fjeldså E; Holdaas H
Atorvastatin improves endothelial function in renal-transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(9):1920-4.
-
2001: Midtvedt K; Ihlen H; Hartmann A; Bryde P; Bjerkely B L; Foss A; Fauchald P; Holdaas H
Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study.
Transplantation 2001;72(1):107-11.
-
2001: Holdaas H; Fellström B; Holme I; Nyberg G; Fauchald P; Jardine A; Grönhagen-Riska C; Madsen S; Neumayer H H; Cole E; Maes B; Weinreich T; Olsson A G; Pedersen T R; Benghozi R; Hartmann A;
Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data.
Journal of cardiovascular risk 2001;8(2):63-71.
-
2001: Linde T; Ekberg H; Forslund T; Furuland H; Holdaas H; Nyberg G; Tydén G; Wahlberg J; Danielson B G
The use of pretransplant erythropoietin to normalize hemoglobin levels has no deleterious effects on renal transplantation outcome.
Transplantation 2001;71(1):79-82.
-
1999: Jardine A; Holdaas H
Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience.
Journal of clinical pharmacy and therapeutics 1999;24(6):397-408.
-
1998: Holdaas H; Hartmann A; Berg K J; Lund K; Fauchald P
Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(12):3096-102.
-
1996: Hartmann A; Andereassen A K; Holdaas H; Simonsen S; Geiran O; Berg K J
Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1996;15(10):972-9.
-
1996: Midtvedt K; Tafjord A B; Hartmann A; Eide T C; Holdaas H; Nordal K P; Draganov B; Sødal G; Leivestad T; Fauchald P
Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection.
Transplantation 1996;62(1):38-42.
-
1996: Nyberg G; Holdaas H; Brekke I B; Hartmenn A; Norden G; Olausson M; Osterby R
Glomerular ultrastructure in kidneys transplanted simultaneously with a segmental pancreas to patients with type 1 diabetes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(6):1029-33.
-
1995: Reisaeter A V; Leivestad T; Albrechtsen D; Holdaas H; Hartmann A; Sødal G; Flatmark A; Fauchald P
Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients.
Transplantation 1995;60(3):242-8.
-
1995: Holdaas H; Hartmann A; Stenstrøm J; Dahl K J; Borge M; Pfister P
Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine.
The American journal of cardiology 1995;76(2):102A-106A.
-
1995: Brekke I B; Bentdal O; Pfeffer P; Lien B; Sødal G; Holdaas H; Fauchald P; Jervell J
[Pancreas transplantation. A 10-year material]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1995;115(6):703-5.
-
1995: Holdaas H; Hartmann A; Berg K J; Langberg H; Blystad L; Fauchald P
Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy.
Journal of internal medicine 1995;237(1):63-71.
-
1995: Tonstad S; Holdaas H; Gørbitz C; Ose L
Is dietary intervention effective in post-transplant hyperlipidaemia?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(1):82-5.
-
1994: Hartmann A; Lund K; Holdaas H; Fauchald P; Reisaeter A; Berg K J
Contrasting short-term effects of nifedipine on glomerular and tubular functions in glomerulonephritic patients.
Journal of the American Society of Nephrology : JASN 1994;5(6):1385-90.
-
1994: Bentdal O H; Brekke I B; Lien B; Pfeffer P F; Sødal G; Hartmann A; Holdaas H; Nordal K P; Fauchald P
Rapid development of cancer in both kidney grafts after transplantation from a donor with undiagnosed malignant disease.
Transplantation proceedings 1994;26(3):1763.
-
1994: Reisaeter A V; Fauchald P; Leivestad T; Holdaas H; Hartmann A; Pfeffer P; Sødal G
Plasma exchange in highly sensitized patients as induction therapy after renal transplantation.
Transplantation proceedings 1994;26(3):1758.
-
1994: Hartmann A; Reisaeter A; Holdaas H; Rolfsen B; Fauchald P
Accidental metabolic acidosis during hemodialysis.
Artificial organs 1994;18(3):214-7.
-
1994: Holdaas H; Andersson R; Fauchald P; Albrechtsen D
[Infection in patients with organ transplants]
Nordisk medicin 1994;109(6-7):194-6.
-
1992: Hartmann A; Holdaas H; Fauchald P; Nordal K P; Berg K J; Talseth T; Leivestad T; Brekke I B; Flatmark A
Fifteen years' experience with renal transplantation in systemic amyloidosis.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5(1):15-8.
-
1992: Fauchald P; Vatne K; Paulsen D; Brodahl U; Sødal G; Holdaas H; Berg K J; Flatmark A
Long-term clinical results of percutaneous transluminal angioplasty in transplant renal artery stenosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1992;7(3):256-9.
-
1991: Endresen L; Bergan S; Holdaas H; Pran T; Sinding-Larsen B; Berg K J
Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients.
Therapeutic drug monitoring 1991;13(6):490-5.
-
1991: Holdaas H; Brekke I B; Hartmann A; Bentdal O H; Ganes T; Gjellestad A; Fauchald P; Berg K J; Djøseland O; Jervell J
Long-term metabolic control in recipients of combined pancreas and kidney transplants.
Diabetologia 1991;34 Suppl 1():S68-70.
-
1991: Bentdal O H; Fauchald P; Brekke I B; Holdaas H; Hartmann A
Rehabilitation and quality of life in diabetic patients after successful pancreas-kidney transplantation.
Diabetologia 1991;34 Suppl 1():S158-9.
-
1991: Hartmann A; Holdaas H
[Therapeutic principles in hyperkalemia]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1991;111(18):2275-7.
-
1991: Holdaas H; Brekke I B; Hartmann A; Fauchald P; Bentdal O; Søodal G; Jervell J; Flatmark A
Long-term glucose control following combined kidney and pancreatic transplantation.
Transplantation proceedings 1991;23(1 Pt 2):1656-7.
-
1991: Holdaas H; Hartmann A; Lien M G; Nilsen L; Jervell J; Fauchald P; Endresen L; Djøseland O; Berg K J
Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy.
Journal of internal medicine 1991;229(2):163-70.
-
1991: Berg K J; Holdaas H; Endresen L; Fauchald P; Hartmann A; Pran T; Solbu D
Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1991;6(10):725-30.
-
1991: Hartmann A; Charania B; Sund S; Holdaas H; Fauchald P; Flatmark A
Interstitial nephritis with extensive calcium deposits as a cause of renal allograft failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1991;6(12):984-8.
-
1990: Brekke I B; Holdaas H; Albrechtsen D; Fauchald P; Flatmark A
Combined pancreatic and renal transplantation: improved survival of uremic diabetic patients and renal grafts.
Transplantation proceedings 1990;22(4):1580.
-
1990: Holdaas H; Brekke I B; Hartmann A; Fauchald P; Berg K J; Sødal G; Jervell J; Flatmark A
Metabolic control in recipients of duct-occluded segmental pancreatic grafts: a four-year follow-up.
Transplantation proceedings 1990;22(2):655-6.
-
1990: Norstein J; Brekke I B; Holdaas H; Vatne K
Arterial stenoses in duct occluded segmental pancreatic grafts treated with percutaneous transluminal angioplasty.
Transplantation proceedings 1990;22(2):599-601.
-
1990: Holdaas H; Hartmann A; Talseth T; Fauchald P; Sødal G; Brekke I B; Berg K J
Change in intrarenal sodium reabsorption following donor nephrectomy.
Transplantation proceedings 1990;22(1):246.
-
1989: Holdaas H; Brekke I B; Hartmann A; Talseth T; Sødal G; Jervell J; Flatmark A
Long-term metabolic control in recipients of duct-occluded segmental pancreatic grafts.
Transplantation proceedings 1989;21(1 Pt 3):2854-5.
-
1989: Tydén G; Brattström C; Bolinder J; Bohman S O; Groth C G; Brekke I B; Holdaas H; Flatmark A
Long-term metabolic control in recipients of segmental-pancreas grafts with pancreaticoenterostomy or duct obstruction.
Diabetes 1989;38 Suppl 1():94-6.
-
1988: Holdaas H; Hartmann A; Talseth T; Berg K J; Fauchald P; Stenstrøm J; Djøseland O; Nordal K P; Brodwall E
Short-term changes in renal function of the remaining kidney after donor nephrectomy.
Transplantation proceedings 1988;20(3):434-5.
-
1988: Holdaas H; Talseth T; Berg K J; Fauchald P; Nordal K P; Hartmann A
Diagnostic value of peripheral plasma renin response to a single dose of captopril in suspected renal transplant artery stenosis.
Transplantation proceedings 1988;20(3):423-4.
-
1988: Talseth T; Holdaas H; Albrechtsen D; Berg K J; Fauchald P; Naalsund A; Nordal K P; Skar A G; Sødal G; Flatmark A
Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients.
Transplantation proceedings 1988;20(3):400-1.
Sign-in to see more